论文部分内容阅读
本文对69例中晚期原发性肝癌行肝动脉灌注化疗(THAI)及栓塞术(TAE)96次。结果显示:肿瘤缩小占62.2%,甲胎蛋白不同程度下降占55.6%。生存期延长:生存3个月以上88.4%,6个月56.5%以上。经验表明THAI与TAE是一种有效的方法,对不能手术切除的肝癌患者应作为首选疗法。
In this article, 69 cases of advanced hepatocellular carcinoma were treated with hepatic arterial infusion chemotherapy (THAI) and embolization (TAE) 96 times. The results showed that tumor shrinkage accounted for 62.2%, and alpha-fetoprotein decreased by 55.6%. The survival period is prolonged: 88.4% survived for more than 3 months and 56.5% more than 6 months. Experience has shown that THAI and TAE are an effective method and should be used as the first choice for patients with unresectable liver cancer.